Alamar Biosciences IPO Review
Alamar Biosciences IPO Pages
📝
Detailed review coming soon
Our editorial team is preparing an in-depth analysis of Alamar Biosciences IPO covering company financials, valuation, strengths, risks and apply-or-skip verdict. Below is the structured information we have confirmed so far.
Price / Issue Price
$17
Issue Size
$191 M
Type
Mainboard
Exchange
Nasdaq
Sector
Healthcare & Pharma
Already listed.
Issued at $17, listed at $22
(+29.41%)
on 17 Apr 2026.
About Alamar Biosciences
Alamar Biosciences develops ultra-sensitive proteomics technology for early disease detection and therapeutic research. Its platform enables identification of low-abundance biomarkers for oncology and neurology applications.
IPO Details
- Type
- Mainboard
- Country
- United States
- Sector
- Healthcare & Pharma
- Registrar
- Link Intime